Delivery Order SPE2DB25D3021-SPE2DB25FQZMD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $6,099.74 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child award under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $22,670.24 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on June 12, 2025, with a completion date of June 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $62,937.18 delivery order from the Defense Logistics Agency (DLA) for 90 tablets of Jardiance 25 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. The award was made under firm fixed-price terms with no set-aside designation, indicating it was competitively awarded. This delivery order is issued as a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,715.58 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract was awarded on April 28, 2025, with an ultimate completion date of April 29, 2025, using firm fixed-price pricing with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.03 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price, non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen Drug Corp's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a $6,240.97 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 21, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a $25,812.07 delivery order to AmerisourceBergen Drug Corp for 90-count packages of Jardiance 25 mg tablets under a firm fixed price contract type. The award was made on September 15, 2025, with an ultimate completion date of September 16, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office...
- The Defense Logistics Agency awarded a $3,504.92 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Jardiance 10 mg tablets (90-count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order is to be fulfilled at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $12,877.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The award represents a child delivery order issued under a larger contract...
- SPE2DB25D3021Indefinite Delivery Contract
- SPE2DB25D3021-SPE2DB25FQZMDDelivery Order
The Defense Logistics Agency awarded a $6,493.73 delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Jardiance 25 mg tablets, with performance at the company's Conshohocken, Pennsylvania location and completion by September 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems worldwide. The current delivery order for Jardiance—a diabetes medication—exemplifies the company's role in fulfilling critical pharmaceutical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 9/3/25 |